Nautilus Biotechnology Inc
NAUT
Get informed when a big investor buys or sells
+ FollowMarket Cap$412.31M
Close$
$-0.14
104.3% downside
Current Fair Value
104.3% downsideOvervalued by 104.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $412.31 Million |
|---|---|
| Enterprise Value | $426.96 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.47 |
| Beta | 0.87 |
| Outstanding Shares | 126,886,646 |
Return
| Return on Equity | -43.11% |
|---|---|
| Return on Assets | -34.55% |
| Return on Invested Capital | -38.24% |
Valuation & Multiples
| P/E Ratio | -7.2 |
|---|---|
| PEG | 191.91 |
| Price to Sales | - |
| Price to Book Ratio | 3.24 |
| Enterprise Value to Revenue | 2247.14 |
| Enterprise Value to EBIT | -7.21 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.21 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$250,000
Average shareholder expectationNext Earnings Call
Expected Date
October 26, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$206,250
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 105.32% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.01%▼ 39.61% |
|---|---|
| Total Invested | $17,543▼ 99.98% |
| Investors Holding | 1▼ 94.00% |
ESG Score
No data